Timely antenatal and postnatal interventions can significantly improve outcomes for severe RhRh factor A protein or antigen found on red blood cells. When an Rh-negative mother carries an Rh-positive fetus, her immune system may make antibodies that attack the fetus' red blood cells.-related hemolytic disease of the fetus and newborn (HDFN), according to a case study published recently in the Caucasian Medical Journal.
Through careful monitoring, intrauterine transfusions and postnatal management, a high-risk pregnancy was stabilized, and the newborn recovered without major complications.
Hallmark HDFN symptoms and an early delivery
The patient was a 42-year-old Rh-negativeRh-Negative A blood type trait that means your red blood cells lack the Rh(D) antigen. woman carrying a Rh-positiveRh-Positive A blood type trait that means your red blood cells have the Rh(D) antigen. fetus. Fetal anemiaAnemia A condition that occurs when the body doesn’t have enough healthy red blood cells to carry oxygen to its tissues. In HDFN, anemia occurs when maternal antibodies destroy fetal red blood cells., a hallmark of severe HDFN, was detected early using Doppler ultrasoundDoppler ultrasound A non-invasive scan that measures blood flow speed in the fetus' brain to diagnose anemia. Specifically, it checks the middle cerebral artery peak systolic velocity (MCA-PSV)., which showed an elevated middle cerebral artery peak systolic velocity, a reliable marker of fetal anemia severity.
At 23 weeks of gestation, the fetus had a dangerously low hemoglobin level of 3 g/dL. An intrauterine transfusionIntrauterine transfusion A procedure that delivers donor red blood cells to the fetus through the umbilical vein to treat severe anemia caused by HDFN. using 87 mL of Rh-negative donor blood improved hemoglobin levels and normalized values for middle cerebral artery peak systolic velocity. A second transfusion at 29 weeks further improved fetal hemoglobin levels to 14.3 g/dL without complications.
“Rh hemolytic disease can be mild (mild anemia and jaundiceJaundice A common symptom of HDFN, jaundice is caused by excess bilirubin and is characterized by a yellow tint to the skin or eyes.) or severe (severe anemia, hydrops fetalisHydrops fetalis A serious, sometimes fatal condition in which fluid builds up in a baby’s tissues and organs due to severe anemia from HDFN. and death). Therefore, antenatal and postnatal follow-up of high-risk babies is important,” the authors wrote. “Currently, the peak systolic velocity of the midbrain artery with Doppler ultrasound, a non-invasive method, is measured to determine the severity of fetal anemia and to perform intrauterine transfusions if necessary. This procedure is performed to prevent severe fetal anemia and other complications.”
Read more about treatment and care of HDFN
Delivery occurred at 34 weeks via cesarean section due to premature membrane rupture and prior uterine scarring. The infant, weighing 4.784 lbs, had an Apgar score of 6/7 and required respiratory support for 24 hours. Postnatal blood tests revealed a hemoglobin level of 8 g/dL, necessitating an exchange transfusion. During this procedure, 350 mL of donor blood was transfused, stabilizing the infant’s hemodynamics and improving hemoglobin levels to 16.7 g/dL. PhototherapyPhototherapy A treatment that uses special blue light to help newborns break down bilirubin and prevent kernicterus. successfully reduced bilirubinBilirubin A yellow substance produced when red blood cells break down. High bilirubin levels in newborns with HDFN can cause jaundice or, in severe cases, brain damage. levels to 6.9 mg/dL, while immune therapy with intravenous immunoglobulinIntravenous immunoglobulin A therapy made from donated antibodies that may help reduce the mother’s immune response and protect the fetus. further supported recovery.
Throughout hospitalization, the newborn showed continuous improvement, with blood tests confirming rising hemoglobin and falling bilirubin levels. Importantly, no complications such as infections, electrolyte imbalances, or circulatory issues were observed, which highlighted the safety and efficacy of these interventions when performed promptly and carefully.
Modern strategies can prevent complications
For families affected by HDFN, these results could provide reassurance that modern techniques—such as Doppler ultrasound monitoring, intrauterine transfusions, and postnatal therapies—can prevent severe complications such as hydrops fetalis, organ damage, and even death. Early diagnosis and close monitoring of fetal anemia played critical roles in this successful outcome.
This case emphasized the importance of teamwork between obstetricians, fetal medicine specialists and neonatologists to deliver precise care for high-risk pregnancies. By combining antenatal and postnatal strategies, severe cases of HDFN can be effectively managed, offering hope to families navigating this challenging condition.
